Market Overview

Vetr Crowd Downgrades Gilead Sciences


The Vetr community on Monday downgraded Gilead Sciences, Inc. (NASDAQ: GILD) from 3.5 stars (Buy) to 3 stars (Hold). Crowd confidence was mixed, with 46.2 percent of Vetr users giving the stock a Buy rating, 30.8 percent a Hold and 23.1 percent a Sell.

See how crowdsourced ratings could help you time the market

At time of publication, Gilead shares were trading down 1.24 percent at $87.70. The Vetr crowd is slightly bullish, setting a price target of $91.25, implying a 3.7 percent upside. However, analysts were bearish, with most recent target prices falling in the $83-$93 price range.


Related Articles (GILD)

View Comments and Join the Discussion!

Posted-In: VetrDowngrades Analyst Ratings

Latest Ratings

WKHSRoth CapitalMaintains15.0
HCKTRoth CapitalMaintains22.0
ARECRoth CapitalInitiates Coverage On7.5
SLABWells FargoMaintains180.0
PENWells FargoMaintains310.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at